Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Labianca

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
The New England Journal of Medicine|October 13, 2001
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patientsD J Sargent, R M Goldberg, S D Jacobson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2020
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upG Argilés, J Tabernero, R Labianca, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2009
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)Alba A Brandes, A Tosoni, E Franceschi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R Labianca, V Catalano, et al.
Tumori|February 24, 2001
The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trialS Mosconi, S Cascinu, A Zaniboni, et al.
British Journal of Cancer|May 12, 2011
Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patientsM Scartozzi, I Bearzi, A Mandolesi, et al.
Journal of Pain and Symptom Management|April 16, 1999
A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative CareM Pirovano, M Maltoni, O Nanni, et al.
Journal of Pain and Symptom Management|April 16, 1999
Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative CareM Maltoni, O Nanni, M Pirovano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II studyL Celio, C N Sternberg, R Labianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trialC Louvet, R Labianca, P Hammel, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
The New England Journal of Medicine|October 13, 2001
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patientsD J Sargent, R M Goldberg, S D Jacobson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2020
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upG Argilés, J Tabernero, R Labianca, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2009
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)Alba A Brandes, A Tosoni, E Franceschi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R Labianca, V Catalano, et al.
Tumori|February 24, 2001
The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trialS Mosconi, S Cascinu, A Zaniboni, et al.
British Journal of Cancer|May 12, 2011
Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patientsM Scartozzi, I Bearzi, A Mandolesi, et al.
Journal of Pain and Symptom Management|April 16, 1999
A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative CareM Pirovano, M Maltoni, O Nanni, et al.
Journal of Pain and Symptom Management|April 16, 1999
Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative CareM Maltoni, O Nanni, M Pirovano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II studyL Celio, C N Sternberg, R Labianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trialC Louvet, R Labianca, P Hammel, et al.
Pageof 17